Free Trial

Oncolytics Biotech (ONCY) Short Interest Ratio & Short Volume

→ Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad)
Free ONCY Stock Alerts
$1.06
-0.04 (-3.64%)
(As of 05/23/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Oncolytics Biotech Short Interest Data

Current Short Interest
861,200 shares
Previous Short Interest
928,100 shares
Change Vs. Previous Month
-7.21%
Dollar Volume Sold Short
$955,932.00
Short Interest Ratio
2.5 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
75,850,000 shares
Percentage of Shares Shorted
1.14%
Today's Trading Volume
202,191 shares
Average Trading Volume
338,733 shares
Today's Volume Vs. Average
60%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Oncolytics Biotech ?

Sign up to receive the latest short interest report for Oncolytics Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ONCY Short Interest Over Time

ONCY Days to Cover Over Time

ONCY Percentage of Float Shorted Over Time

Oncolytics Biotech Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024861,200 shares $955,932.00 -7.2%N/A2.5 $1.11
4/15/2024928,100 shares $983,786.00 -0.3%N/A2.5 $1.06
3/31/2024930,700 shares $986,542.00 +1.2%N/A2.3 $1.06
3/15/2024919,700 shares $909,491.33 -11.6%N/A2.2 $0.99
2/29/20241,040,000 shares $1.19 million +12.6%N/A2.3 $1.14
2/15/2024923,400 shares $1.07 million +38.7%N/A2.2 $1.16
1/31/2024666,000 shares $792,540.00 -40.0%N/A1.5 $1.19
1/15/20241,110,000 shares $1.35 million +0.9%N/A2.6 $1.22
12/31/20231,100,000 shares $1.49 million -7.6%N/A2.5 $1.35
12/15/20231,190,000 shares $1.61 million -16.8%N/A2.9 $1.35
11/30/20231,430,000 shares $2.07 million -4.0%N/A3.6 $1.45
11/15/20231,490,000 shares $2.21 million -6.9%N/A3.4 $1.48
10/31/20231,600,000 shares $2.66 million +12.7%N/A3.2 $1.66
10/15/20231,420,000 shares $2.64 million -2.1%N/A2.3 $1.86
9/30/20231,450,000 shares $3.16 million -8.8%N/A2.2 $2.18
9/15/20231,590,000 shares $3.42 million -2.5%N/A1.9 $2.15
8/31/20231,630,000 shares $3.73 million +38.1%N/A1.4 $2.29
8/15/20231,180,000 shares $2.43 million -38.9%N/A1 $2.06
7/31/20231,930,000 shares $4.86 million +39.9%N/A1.9 $2.52
7/15/20231,380,000 shares $4.07 million +12.2%N/A1.6 $2.95
6/30/20231,230,000 shares $3.20 million +256.3%N/A1.6 $2.60
6/15/2023345,200 shares $673,140.00 +6.0%N/A0.6 $1.95
5/31/2023325,600 shares $527,472.00 +104.3%N/A1.4 $1.62
5/15/2023159,400 shares $261,416.00 +133.7%N/A0.9 $1.64
4/30/202368,200 shares $99,565.18 -8.2%N/A0.4 $1.46
4/15/202374,300 shares $85,445.00 -35.8%N/A0.4 $1.15
3/31/2023115,800 shares $138,960.00 -45.8%N/A0.6 $1.20
3/15/2023213,700 shares $284,221.00 +15.1%N/A1 $1.33
2/28/2023185,700 shares $284,121.00 +4.6%N/A0.7 $1.53
2/15/2023177,500 shares $296,425.00 +29.5%N/A0.6 $1.67
1/31/2023137,100 shares $244,038.00 +45.9%N/A0.4 $1.78
1/15/202394,000 shares $155,100.00 +57.5%N/A0.3 $1.65
12/30/202259,700 shares $97,311.00 -54.8%N/A0.2 $1.63
12/15/2022132,200 shares $241,926.00 +91.9%N/A0.5 $1.83
11/30/202268,900 shares $121,264.00 -38.0%N/A0.4 $1.76
11/15/2022111,200 shares $173,472.00 -3.1%N/A1 $1.56
10/31/2022114,700 shares $144,522.00 -29.9%N/A1.2 $1.26
10/15/2022163,500 shares $199,470.00 +1.5%N/A1.9 $1.22
9/30/2022161,100 shares $198,153.00 -19.2%N/A1.9 $1.23
9/15/2022199,300 shares $259,090.00 -23.1%N/A1.9 $1.30
Who are Nvidia’s Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”
8/31/2022259,000 shares $371,846.30 +9.5%N/A2.2 $1.44
8/15/2022236,600 shares $313,495.00 +10.1%N/A1.9 $1.33
7/31/2022215,000 shares $246,648.00 -5.0%N/A1.8 $1.15
7/15/2022226,400 shares $223,004.00 -36.8%N/A2.1 $0.99
6/30/2022358,000 shares $361,580.00 +102.8%N/A2.6 $1.01
6/15/2022176,500 shares $158,850.00 -17.2%N/A1.4 $0.90
5/31/2022213,100 shares $249,327.00 +22.3%N/A1.6 $1.17
5/15/2022174,300 shares $200,445.00 -35.3%N/A1.1 $1.15
4/30/2022269,400 shares $355,608.00 +15.4%N/A1.4 $1.32
4/15/2022233,400 shares $350,100.00 +53.7%N/A0.9 $1.50
3/31/2022151,900 shares $240,002.00 +25.4%N/A0.4 $1.58
3/15/2022121,100 shares $184,072.00 -36.6%N/A0.3 $1.52
2/28/2022191,100 shares $324,870.00 +1.4%N/A0.5 $1.70
2/15/2022188,400 shares $359,844.00 -35.9%0.4%0.5 $1.91
1/31/2022293,900 shares $558,410.00 +124.9%0.5%0.7 $1.90
1/15/2022130,700 shares $211,734.00 -12.4%0.2%0.3 $1.62
12/31/2021149,200 shares $207,388.00 -45.6%0.3%0.6 $1.39
12/15/2021274,000 shares $424,700.00 +9.3%0.5%1.1 $1.55
11/30/2021250,700 shares $423,683.00 +11.3%0.5%1.1 $1.69
11/15/2021225,200 shares $427,880.00 -30.4%0.4%1.1 $1.90
10/29/2021323,600 shares $660,144.00 +19.8%0.6%1.7 $2.04
10/15/2021270,200 shares $599,844.00 +64.5%0.5%1.5 $2.22
9/30/2021164,300 shares $343,387.00 -12.9%0.3%0.9 $2.09
9/15/2021188,600 shares $380,972.00 -37.3%0.4%0.9 $2.02
8/31/2021300,900 shares $695,079.00 -27.1%0.6%1.4 $2.31
8/13/2021412,600 shares $862,334.00 -15.4%0.8%1.4 $2.09
7/30/2021487,700 shares $1.13 million -3.6%0.9%1.4 $2.32
7/15/2021505,700 shares $1.12 million +11.7%0.9%1.2 $2.22
6/30/2021452,900 shares $1.25 million -15.4%0.8%0.8 $2.77
6/15/2021535,600 shares $1.51 million -33.2%1.0%0.5 $2.82
5/28/2021802,200 shares $2.45 million -21.4%1.5%0.7 $3.05
5/14/20211,020,000 shares $2.65 million +10.3%1.9%0.7 $2.60
4/30/2021924,700 shares $2.83 million -7.5%1.8%0.5 $3.06
4/15/20211,000,000 shares $3.07 million -32.4%1.9%0.5 $3.07
3/31/20211,480,000 shares $5.40 million -15.4%2.9%0.7 $3.65
3/15/20211,750,000 shares $5.23 million +96.4%3.4%1 $2.99
2/26/2021891,000 shares $3.09 million +7.5%2.0%0.5 $3.47
2/12/2021828,800 shares $2.24 million -65.2%1.8%0.4 $2.70
1/29/20212,380,000 shares $5.95 million +21.4%5.6%1.7 $2.50
1/15/20211,960,000 shares $5.63 million -1.0%4.6%1.5 $2.87
12/31/20201,980,000 shares $4.79 million +14.5%4.7%1.7 $2.42
12/15/20201,730,000 shares $4.38 million +3.0%4.1%1.6 $2.53
11/30/20201,680,000 shares $4.65 million -12.0%3.9%1.9 $2.77
11/15/20201,910,000 shares $3.84 million +9.8%4.5%3.3 $2.01
10/30/20201,740,000 shares $3.57 million -0.6%4.2%4 $2.05
10/15/20201,750,000 shares $3.70 million -10.3%4.3%3.9 $2.12
9/30/20201,950,000 shares $3.30 million -3.5%4.8%4.2 $1.69
9/15/20202,020,000 shares $3.47 million -7.3%4.9%4.2 $1.72
8/31/20202,180,000 shares $3.84 million +3.8%5.3%4.3 $1.76
8/14/20202,100,000 shares $3.51 million +1.9%5.1%3.3 $1.67
Who are Nvidia’s Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”
7/31/20202,060,000 shares $4.16 million +6.2%5.0%2.2 $2.02
7/15/20201,940,000 shares $3.84 million -0.5%7.5%2 $1.98
6/30/20201,950,000 shares $3.67 million +1.6%7.5%2.2 $1.88
6/15/20201,920,000 shares $3.69 million +7.9%7.4%2 $1.92
5/29/20201,780,000 shares $4.34 million +18.7%6.9%1.8 $2.44
5/15/20201,500,000 shares $3.03 million +19.1%5.8%1.5 $2.02
4/30/20201,260,000 shares $2.08 million +5.9%4.9%1.7 $1.65
4/15/20201,190,000 shares $1.70 million -5.6%4.6%1.5 $1.43
3/31/20201,260,000 shares $1.69 million -7.6%4.9%1.2 $1.34
3/13/20201,362,900 shares $1.99 million +36.7%5.3%1.7 $1.46
2/28/2020997,400 shares $1.14 million -2.2%3.9%0.6 $1.14
2/14/20201,020,000 shares $1.94 million -31.1%4.0%0.6 $1.90
1/31/20201,480,000 shares $3.42 million -5.1%5.7%0.9 $2.31
1/15/20201,560,000 shares $3.88 million -10.3%6.0%0.9 $2.49
12/31/20191,740,000 shares $5.69 million +14.5%6.7%1.2 $3.27

ONCY Short Interest - Frequently Asked Questions

What is Oncolytics Biotech's current short interest?

Short interest is the volume of Oncolytics Biotech shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 861,200 shares of ONCY short. Learn More on Oncolytics Biotech's current short interest.

What is a good short interest ratio for Oncolytics Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONCY shares currently have a short interest ratio of 2.0. Learn More on Oncolytics Biotech's short interest ratio.

Is Oncolytics Biotech's short interest increasing or decreasing?

Oncolytics Biotech saw a drop in short interest in April. As of April 30th, there was short interest totaling 861,200 shares, a drop of 7.2% from the previous total of 928,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Oncolytics Biotech's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Oncolytics Biotech: Aclaris Therapeutics, Inc. (8.35%), Barinthus Biotherapeutics plc (0.05%), Tiziana Life Sciences Ltd (0.38%), Hookipa Pharma Inc (0.91%), SELLAS Life Sciences Group, Inc. (12.10%), Spero Therapeutics, Inc. (0.87%), Aileron Therapeutics, Inc. (0.98%), Anixa Biosciences, Inc. (2.08%), Chimerix, Inc. (1.71%), YS Biopharma Co., Ltd. (0.32%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Oncolytics Biotech stock?

Short selling ONCY is an investing strategy that aims to generate trading profit from Oncolytics Biotech as its price is falling. ONCY shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncolytics Biotech?

A short squeeze for Oncolytics Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCY, which in turn drives the price of the stock up even further.

How often is Oncolytics Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCY, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:ONCY) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks
Crypto 101 Media
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Write this ticker symbol down…
StocksToTrade
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
This could mean the end of the U.S dollar…
Colonial Metals
This military-backed stock “owns” AI market
Porter & Company
Buy this small stock before coming AI Tidal Wave
Chaikin Analytics